Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
FROM MID-OCTOBER, news reports across the world began to describe surging cases of respiratory syncytial virus, or RSV, a common seasonal respiratory illness that most children are infected with before the age of two.
For the most part, RSV is a mild illness, but for some babies, young children, and elderly people, it can lead to serious infection and hospital admission. In a very small number of cases, RSV can kill.
There are a number of theories as to why RSV cases are unusually high this season.
Research suggests that the seasonality of RSV has changed since the Covid-19 pandemic, with outbreaks taking place earlier in the year. This is likely because of the use of masks and social distancing during 2020 and 2021, which would have limited the spread of the virus.
Some people have pointed to an explanation known as ‘immunity debt’ to claim that lockdowns weakened immune systems, although many have highlighted a lack of evidence for this hypothesis and said it goes against the fundamentals of how our immune systems work.
Others are examining whether Covid-19 infections may have damaged children’s immune systems, putting them at higher risk of serious infection.
This surge in RSV infections, coupled with rising cases of flu and Covid-19 (being dubbed in some quarters as a ‘tripledemic’) has led to paediatric hospital units being stretched to their limit in a number of countries including the US, the UK and Germany, putting the lives of children at risk.
Conspiracy theorists
As healthcare workers attempted to sound the alarm and warn people about the risks, online communities that had dedicated themselves to spreading false information about Covid-19 and vaccines turned their attention to RSV, making the dissemination of accurate information even more difficult.
Nowhere is this more apparent than in conversation about RSV taking place on Twitter.
Discussions about the virus began to increase on Twitter in mid-October as news reports emerged of surging infections.
An analysis of the most-engaged tweets about RSV between 12 October and 12 November found that in the first three weeks (12 October – 5 November) the top ten most engaged tweets were primarily from healthcare workers describing the worsening conditions in hospitals and fears of the consequences of a lack of paediatric beds.
During the week of 5 November – 12 November, this conversation changed dramatically. Eight of the top ten tweets that week disseminated some kind of false information about RSV.
This misinformation often centered claims that Covid-19 vaccines are responsible for the RSV surge. One of the most consistent claims being spread was that the Covid-19 vaccines were to blame for the RSV surge.
This claim stemmed in large part from a segment on The Highwire, an anti-vaccine and science denial website founded by Del Bigtree, a prominent anti-vaccine campaigner and producer of the propaganda film Vaxxed.
In the segment, Bigtree and his guest use the common science denial tactic of cherry picking to point the finger at Covid-19 vaccines for rising RSV infections.
Using FDA documents discussing the results of clinical trials for the Moderna and Pfizer vaccines in children, they pull out sentences that describe small increases in RSV infections in vaccine groups compared to placebo groups.
In both instances, they ignore the parts of the reports concluding the increases seen were not viewed as unusual and were found not to have a causal link to the vaccines. Instead, they falsely concluded that this is evidence of a link between RSV and Covid-19 vaccines.
This segment was widely shared and repurposed within online communities that promote health and science misinformation, even forming the basis for the most highly engaged tweet seen in our data set in the whole period analyzed (12 October – 12 November).
Twitter
Twitter
‘Traitorous Americans’
Another highly engaged tweet that week contained a clip of Leigh Dundas, a lawyer and notorious anti-vaccine activist from Orange County, California.
According to the LA Times, Dundas has previously harassed and doxxed health officials over mask mandates and was present in Washington on 5 and 6 January, 2021 where she called for the execution of “traitorous Americans”.
The video of Dundas that went viral within RSV discussions featured her addressing the Orange County Board of Supervisors after they declared a health emergency due to surging cases of RSV and other childhood respiratory viruses, which allowed the county to acquire more hospital beds for children.
Advertisement
In the video, Dundas compared the board to Adolf Hitler and Nazi propagandist Joseph Goebbels (Nazi comparisons are a tactic she has become known for), and downplayed the impact of RSV saying it was “nowhere near an emergency”.
She then stated, visually agitated, that she will not accept mask mandates, quarantines or lockdowns, despite the fact that these were not part of the health emergency plan.
Another cause for the spike in RSV misinformation during the week of 5-12 November came from the news that a number of RSV vaccines were close to approval.
GSK’s vaccine for older adults is expected to be approved by the FDA in May 2023, while a vaccine developed by Pfizer, which will be given to expectant mothers to pass immunity onto their child, has seen very positive results in stage three clinical trials. Others are being developed by Moderna and Johnson and Johnson.
In the past, efforts to create an RSV vaccine have failed (and even led to the death of two infants who were given the shot), but a breakthrough discovery in 2013 breathed fresh life into the possibility of immunization against the virus.
Such a development would prevent the level of illness being seen today, and alleviate the pressure on hospitals and healthcare workers across the world.
Grave danger
News of vaccines being developed for RSV did not sit well within the anti-vaccine community, who generally see any new vaccine development as a grave danger.
On 2 November, UK Column – which, according to NewsGuard, is an anti-establishment ‘news’ site that has peddled disinformation about Covid-19 throughout the pandemic – ran a segment claiming children “do not need” an RSV vaccine and that immunizing fetuses in utero was “horrifying”.
The guest also discussed how “convenient” it was that vaccines were being developed for RSV at the same time as the media was reporting a surge in infections, implying that it was part of a sinister plan by the pharmaceutical industry.
Twitter users shared clips of the segment, which was eventually picked up in an article by The Gateway Pundit on 7 November, further pushing the narrative that RSV vaccines would “kill” unborn children. The Gateway Pundit article also spread these theories to a US audience, where the rhetoric became increasingly extreme.
On 10 November, conspiracy theorist Stew Peters invited Stella Immanuel, who notoriously claimed hydroxychloroquine could cure Covid-19, onto his show.
During the interview, Peters and Immanuel used the news about RSV to push various false claims about vaccines, saying that the government wants “to make sure that the mRNA technology gets into everybody because their whole idea is to monitor the whole of the human race”.
Immanuel encouraged viewers to take their chances with diseases such as monkeypox and Ebola, saying “if you have to die, give your life to Christ… do not get genetically modified”.
Peters, who recently released an anti-vaccine propaganda film that claimed the Covid-19 vaccines were part of a depopulation plan, said that the people involved in “inventing, manufacturing or coercion” of vaccines should be “immediately arrested, indicted, tried and if convicted, they would be fried – publicly executed”.
The UK Column clip was later featured in a 12 November segment of Good Morning CHD, the Children’s Health Defense’s daily news show.
A clip from the UK Column which went viral on Twitter during the week of November 5-12 Twitter
Twitter
The CHD segment featured Judy Mikovits, the virologist who made false and misleading claims about Covid-19 in the viral ‘Plandemic’ video in May of 2020.
In the CHD segment, Mikovits urged viewers to take ivermectin for cold-like symptoms, and hydroxychloroquine to treat not only COVID but also “any other RNA virus, the common cold, Zika, Ebola”. Mikovits also claimed a vaccine would destroy “the immune system of the infant before they are born”.
The UK Column, Stew Peters, and Good Morning CHD segments all aired around the aforementioned 5–12 November time frame, correlating with the spike in RSV-related misinformation and coalescing around mainstream media reports of RSV vaccine development.
Predictable trajectory
The discourse around RSV and related vaccines is the latest in a somewhat predictable trajectory for communities that became engrossed in science denial, Covid-skepticism and anti-vaccine rhetoric since 2020.
In 2022 alone, these groups and individuals have turned their attention to spreading false information about monkeypox, polio and RSV, with Strep A looking set to be the next target.
Many involved in these communities have embraced a conspiratorial worldview, which is defined by Professor of Political Science Michael Barkun as having three main components: the belief that everything is connected; that nothing is as it seems; and that nothing happens by accident.
This leaves followers of these theories open to alternative explanations for what happens in the world and encourages them to see sinister connections where they don’t exist, such as viewing the surge in RSV cases and media reporting about RSV vaccines as proof of an ominous plot.
These viral narratives are often repeated and recycled, borrowing elements from the claims that circulated about the Covid-19 pandemic, or anti-vaccine rhetoric that has circulated for years.
The core tenets of science denial are usually present – the use of cherry picking, the demand of impossible standards (such as proving that vaccines are 100% safe), the presence of bad experts (such as Judy Mikovits or Stella Immanuel), and of course the use of conspiracy theories to give their claims an enticing narrative.
We can expect this pattern to continue with every virus or disease outbreak and every vaccine development in the future.
Aoife Gallagher and Clara Martiny are researchers with the Institute for Strategic Dialogue, a counter extremism think-tank working to push back against the rising tide of extremism, polarisation and hate on a global scale.
Readers like you are keeping these stories free for everyone...
It is vital that we surface facts from noise. Articles like this one brings you clarity, transparency and balance so you can make well-informed decisions.
We set up FactCheck in 2016 to proactively expose false or misleading information, but to continue to deliver on this mission we need your support.
Over 5,000 readers like you support us. If you can, please consider setting up a monthly payment or making a once-off donation to keep news free to everyone.
FactCheck
The Journal's monthly FactCheck newsletter keeps you in the loop about what misinformation trends Ireland is experiencing - and how we're fighting back. Sign up here
An Israeli drone circled over the Irish base camp in Lebanon monitoring Simon Harris' visit
Niall O'Connor
Reporting from Lebanon
Updated
3 hrs ago
14.3k
United States
EU pledges to 'protect our workers' as Trump announces 25% tariffs on all cars made outside US
3 hrs ago
22.9k
38
As it happened
Verona Murphy 'fully intends' to continue as Ceann Comhairle as opposition parties draft no confidence motion
5 hrs ago
51.3k
101
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 160 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 142 partners can use this purpose
Use limited data to select advertising 112 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 133 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 59 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say